One reason glioblastoma — the most aggressive brain cancer, with only about 7% five-year survival — is so deadly is that surgeons can’t see or remove every last tumor cell. A new nanoparticle offers a two-in-one answer: make the tumor glow, then kill what’s left.
Researchers at the University of Technology Sydney, with Harvard and Henan University, led by Dr. Bingyang Shi, engineered nanoparticles that work in two steps. First, a fluorescent dye glows under near-infrared light, revealing tumor clusters as small as 44 micrometers (about half a hair’s width) to guide surgery. Then, after surgery, platinum atoms convert the tumor’s hydrogen peroxide into oxygen — countering the low-oxygen environment that shields cancer cells — while light generates heat and reactive molecules to destroy microscopic residual cells. The work appeared in Science Translational Medicine.
Striking results in mice
Treated mice showed 100% survival at 60 days, compared with about 42 days for surgery alone, along with reduced tumor recurrence and no detectable neurological or motor impairments.
Why it matters — and the caveat
Combining precise surgical imaging with a mop-up therapy in one system directly targets glioblastoma’s biggest weakness: the cells left behind. But the team is careful. “The results are very encouraging, but this is still early-stage research carried out in” animals, Shi emphasized — it has not been tested in humans. This article summarizes preclinical research and is not medical advice.